189 related articles for article (PubMed ID: 10207013)
1. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase.
Rajavashisth TB; Liao JK; Galis ZS; Tripathi S; Laufs U; Tripathi J; Chai NN; Xu XP; Jovinge S; Shah PK; Libby P
J Biol Chem; 1999 Apr; 274(17):11924-9. PubMed ID: 10207013
[TBL] [Abstract][Full Text] [Related]
2. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.
Rajavashisth TB; Xu XP; Jovinge S; Meisel S; Xu XO; Chai NN; Fishbein MC; Kaul S; Cercek B; Sharifi B; Shah PK
Circulation; 1999 Jun; 99(24):3103-9. PubMed ID: 10377072
[TBL] [Abstract][Full Text] [Related]
3. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP.
Han YP; Tuan TL; Wu H; Hughes M; Garner WL
J Cell Sci; 2001 Jan; 114(Pt 1):131-139. PubMed ID: 11112697
[TBL] [Abstract][Full Text] [Related]
5. Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells.
Honda S; Migita K; Hirai Y; Origuchi T; Yamasaki S; Kamachi M; Shibatomi K; Fukuda T; Kita M; Hida A; Ida H; Aoyagi T; Kawakami A; Kawabe Y; Oizumi K; Eguchi K
Clin Exp Immunol; 2001 Oct; 126(1):131-6. PubMed ID: 11678909
[TBL] [Abstract][Full Text] [Related]
6. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells.
Haas TL; Davis SJ; Madri JA
J Biol Chem; 1998 Feb; 273(6):3604-10. PubMed ID: 9452488
[TBL] [Abstract][Full Text] [Related]
8. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
Dahi S; Lee JG; Lovett DH; Sarkar R
J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines.
Uzui H; Harpf A; Liu M; Doherty TM; Shukla A; Chai NN; Tripathi PV; Jovinge S; Wilkin DJ; Asotra K; Shah PK; Rajavashisth TB
Circulation; 2002 Dec; 106(24):3024-30. PubMed ID: 12473546
[TBL] [Abstract][Full Text] [Related]
10. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
11. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.
Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B
Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043
[TBL] [Abstract][Full Text] [Related]
14. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
15. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation.
Ben-Yosef Y; Lahat N; Shapiro S; Bitterman H; Miller A
Circ Res; 2002 Apr; 90(7):784-91. PubMed ID: 11964371
[TBL] [Abstract][Full Text] [Related]
16. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts.
Afzal S; Lalani EN; Poulsom R; Stubbs A; Rowlinson G; Sato H; Seiki M; Stamp GW
Hum Pathol; 1998 Feb; 29(2):155-65. PubMed ID: 9490275
[TBL] [Abstract][Full Text] [Related]
17. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells.
Li D; Liu L; Chen H; Sawamura T; Ranganathan S; Mehta JL
Circulation; 2003 Feb; 107(4):612-7. PubMed ID: 12566375
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
19. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
20. LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells.
Sugimoto K; Ishibashi T; Sawamura T; Inoue N; Kamioka M; Uekita H; Ohkawara H; Sakamoto T; Sakamoto N; Okamoto Y; Takuwa Y; Kakino A; Fujita Y; Tanaka T; Teramoto T; Maruyama Y; Takeishi Y
Cardiovasc Res; 2009 Oct; 84(1):127-36. PubMed ID: 19487339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
